Modern pharmacological treatment of obese patients

Chronodisruption as an emerging determinant of weight loss trajectories aft...

Effect of GLP-1 receptor agonists at doses for obesity management on muscle...

Antiobesity medications for older adults—the new, the good, the bad, and...

Probiotics and functional foods in metabolic disease: emerging solutions fo...

Guideline Recommendations for Obesity Management

Altered eating experience during GLP-1 receptor agonist therapy: a sensory�...

Obesity and nonalcoholic fatty liver disease: From pathophysiology to thera...

Bariatric surgeons’ views on pre-operative factors associated with im...

An algorithm for the use of anti-obesity medications